Aquestive Therapeutics, Inc. (AQST) Balance Sheet
As of 2026-06-30 (10-Q), Aquestive Therapeutics, Inc. (AQST) reported total assets of $132.1M, total liabilities of $188.7M and shareholders' equity of -$56.6M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $98.5M. Long-term debt: $55.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AQSTAquestive Therapeutics, Inc.Follow AQST — free
—
Price chart with a free account
- Market cap
- 502.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 60.6 | 49.3 | 31.8 | 28.0 | 27.3 | 23.9 | 71.5 | 121.2 | 98.5 | |
| Receivables | — | — | — | — | — | 8.5 | 7.3 | 17.8 | 9.3 | |
| Inventory | 5.4 | 2.9 | 2.5 | 4.0 | 5.8 | 6.8 | 6.0 | 6.2 | 7.4 | |
| Current assets | 74.2 | 68.3 | 44.6 | 47.3 | 39.9 | 41.0 | 88.2 | 149.3 | 118.5 | |
| Total assets | 86.9 | 78.5 | 62.9 | 62.0 | 57.1 | 57.4 | 101.4 | 160.4 | 132.1 | |
| Current liabilities | 33.0 | 18.6 | 21.1 | 22.0 | 39.5 | 18.3 | 18.9 | 47.6 | 16.5 | |
| Long-term debt | — | 70.0 | 51.5 | — | 33.4 | 45.0 | 45.0 | 45.0 | 55.0 | |
| Short-term debt | — | — | — | — | — | — | — | 10.0 | 0.0 | |
| Total liabilities | 76.8 | 84.6 | 111.4 | 144.1 | 175.6 | 163.9 | 161.6 | 194.1 | 188.7 | |
| Shareholders' equity | 10.1 | -6.1 | -48.5 | -82.1 | -118.6 | -106.5 | -60.2 | -33.7 | -56.6 |
USD millions · SEC XBRL
Aquestive Therapeutics, Inc. — questions
- How much cash does Aquestive Therapeutics, Inc. have?
- $98.5M in cash and cash equivalents as of 2026-06-30.
- How much debt does Aquestive Therapeutics, Inc. have?
- $55.0M of long-term debt and $32000 due within a year as of 2026-06-30.
- What are Aquestive Therapeutics, Inc.'s total assets?
- $132.1M as of 2026-06-30.
- What is Aquestive Therapeutics, Inc.'s shareholders' equity?
- -$56.6M as of 2026-06-30.
Every figure on this page comes from Aquestive Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.